Seeking Alpha
  • Saibus Research
    Teva: Undervalued Industry Leading Generic Drug Maker At 7.5X Adjusted EPS $TEVA
    Reply (2)
    • Mercy Jimenez: Agree but watch entry price; testing results, Israeli/ Iran jitters etc.have swung to $35 recently; I add as it hits $37-39 during meltdowns
    • Saibus Research: Mercy, not a bad entry point. Healthcare sector undervalued relative to its historical multiples and has held up well in the last few months